A team of Japanese scientists led by Professor Hiromi Sakai at Nara Medical University has developed a groundbreaking form of artificial blood that can be safely used in patients of any blood type. This innovation could revolutionize emergency care, battlefield medicine, and medical services in remote areas.
The artificial blood is created using lab-grown red blood cells and platelets encased in microscopic synthetic bubbles. These engineered bubbles allow the artificial blood to perform the essential functions of natural blood, such as transporting oxygen and aiding in blood clotting.
One of its most significant advantages is its long shelf life and ease of storage. Unlike traditional blood, which must be refrigerated and used within a short timeframe, this artificial blood can be stored at room temperature for over a year. This makes it ideal for use in ambulances, hospitals, field clinics, and disaster zones where access to compatible, refrigerated blood is often limited.
“This technology has the potential to transform how we conduct blood transfusions,” said Professor Sakai. “Doctors would no longer need to wait for blood type compatibility tests in emergencies. This could save countless lives.”
Experts say the universal artificial blood could streamline supply management and drastically reduce the risks associated with mismatched transfusions. It could be particularly useful in regions without reliable blood banking systems or during large-scale emergencies such as earthquakes, accidents, or military conflicts.
Clinical trials are set to begin in 2025, and researchers are hopeful about its approval and global rollout by 2030. If successful, this innovation may become a standard component in emergency medical kits—from hospital operating rooms to military deployments and even space missions.
